Illumina Inc
USUSDIllumina Inc (US:ILMN) — Medical Specialities. Брой борси, на които се търгуват акциите на компанията: 2. На тази страница — цена и график, дивиденти, най-големи акционери и история на броя на акциите.
За компанията
- Уебсайт
- illumina.com
- Сектор
- Health Care · Medical Specialities
- Централа
- San Diego, United States
- Служители
- 9 250
- Основана
- 1998
- Акции в обращение
- 151 млн към 2026-07-24
- Свободно търгуеми акции
- 149.78 млн
- Пазарна капитализация
- 41.33 млрд USD
- Инсайдери
- 0.21%
- Институционални инвеститори
- 106.47%
- Отрасъл (SIC)
- Laboratory Analytical Instruments
- ISIN
- US4523271090
- LEI
- SQ95QG8SR5Q56LSNF682
- Коефициент на изплащане
- 0%
- FCF
- 931 млн USD
- Дълг
- 1.49 млрд USD1.6 г. FCF
- Дивидентна история
- —
- Печалба, FCF и изплатени дивиденти — за 12-те месеца до 28.06.2026 (последният отчет на компанията).
Описание
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Дивиденти
| Екс-дата | Изплащане | Сума | % | Вид | Тикер |
|---|---|---|---|---|---|
| 2024-06-25 | — | 3.1051 USD | 1.1/1.1 % | — | LSE:0J8Z |
Новини тази седмица
Прессъобщения от уебсайта на компанията за инвеститори, актуализирани ежедневно. Линковете водят към уебсайта на компанията. Заглавията са на оригиналния език, както е на уебсайта на компанията.
Най-големи притежатели
| Притежател | Дял | Акции | Дата на доклада |
|---|---|---|---|
| Blackrock Inc. | 12.71% | 19.19 млн | 2026-06-30 |
| Capital World Investors | 10.22% | 15.43 млн | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.39% | 6.63 млн | 2026-06-30 |
| Vanguard Capital Managem… | 4.36% | 6.59 млн | 2026-06-30 |
| State Street Corporation | 4.31% | 6.51 млн | 2026-06-30 |
| WCM Investment Managemen… | 4.11% | 6.21 млн | 2026-06-30 |
| iShares Trust-iShares Co… | 3.51% | 5.3 млн | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 3.02% | 4.56 млн | 2026-06-30 |
| FMR, LLC | 3% | 4.52 млн | 2026-06-30 |
| AQR Capital Management,… | 2.35% | 3.54 млн | 2026-06-30 |
| Primecap Management Comp… | 2.33% | 3.51 млн | 2026-06-30 |
| AMERICAN BALANCED FUND | 2.31% | 3.49 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.18% | 3.3 млн | 2026-06-30 |
| Geode Capital Management… | 1.95% | 2.95 млн | 2026-06-30 |
| Growth Fund of America | 1.82% | 2.74 млн | 2026-06-30 |
| New Economy Fund | 1.78% | 2.68 млн | 2026-06-30 |
| VANGUARD HORIZON FUNDS-V… | 1.17% | 1.76 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.15% | 1.74 млн | 2026-06-30 |
| WASHINGTON MUTUAL INVEST… | 1.04% | 1.57 млн | 2026-07-31 |
| NEW PERSPECTIVE FUND | 0.93% | 1.4 млн | 2026-06-30 |
| THAYSEN JACOB (Chief Exe… | ≈0.07% | 109 073 | 2026-03-05 |
| CUNNINGHAM EVERETT V (Of… | ≈0.03% | 50 840 | 2025-03-05 |
| BARNARD STEVEN (Chief Te… | ≈0.03% | 41 335 | 2026-03-05 |
| DHINGRA ANKUR (Chief Fin… | ≈0.02% | 34 264 | 2026-03-05 |
| PEGELS KEVIN CARL (Offic… | ≈0.02% | 29 038 | 2026-03-05 |
| SCHILLER PHILIP W (Direc… | ≈0.01% | 22 220 | 2026-05-21 |
| EPSTEIN ROBERT S (Direct… | ≈0.01% | 22 139 | 2025-05-21 |
| LECKMAN PATRICIA L (Offi… | ≈0.01% | 21 259 | 2026-06-05 |
| ARNOLD FRANCES H PH.D. (… | ≈0.01% | 20 907 | 2025-05-21 |
| MEISTER KEITH A (Directo… | — | — | 2026-09-04 |
